Literature DB >> 9435509

P2U purinergic receptor inhibits apical IsK/KvLQT1 channel via protein kinase C in vestibular dark cells.

D C Marcus1, H Sunose, J Liu, Z Shen, M A Scofield.   

Abstract

Vestibular dark cells (VDC) are known to electrogenically secrete K+ via slowly activating K+ (IsK) channels, consisting of IsK regulatory and KvLQT1 channel subunits, and the associated short-circuit current (Isc) is inhibited by agonists of the apical P2U (P2Y2) receptor (J. Liu, K. Kozakura, and D. C. Marcus. Audit. Neurosci. 2: 331-340, 1995). Measurements of relative K+ flux (JK) with a self-referencing K(+)-selective probe demonstrated a decrease in JK after apical perfusion of 100 microM ATP. On-cell macropatch recordings from gerbil VDC showed a decrease of the IsK channel current (IIsK) by 83 +/- 7% during pipette perfusion of 10 microM ATP. The magnitude of the decrease of Isc by ATP was diminished in the presence of inhibitors of phospholipase C (PLC) and protein kinase C (PKC), U-73122 and GF109203X. Activation of PKC by phorbol 12-myristate 13-acetate (PMA, 20 nM) decreased IIsK by 79 +/- 3% in perforated-patch whole cell recordings, whereas the inactive analog, 4 alpha-PMA, had no effect. In contrast, elevation of cytosolic Ca2+ concentration by A-23187 increased the whole cell IIsK. The expression of the isk gene transcript was confirmed, and the serine responsible for the species-specific response to PKC was found to be present in the gerbil IsK sequence. These data provide evidence consistent with a direct effect of the PKC branch of the PLC pathway on the IsK channel of VDC in response to activation of the apical P2U receptor and predict that the secretion of endolymph in the human vestibular system may be controlled by PKC in the same way as in our animal model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9435509     DOI: 10.1152/ajpcell.1997.273.6.C2022

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  P2Y2 and P2Y4 receptors regulate pancreatic Ca(2+)-activated K+ channels differently.

Authors:  Susanne E Hede; Jan Amstrup; Dan A Klaerke; Ivana Novak
Journal:  Pflugers Arch       Date:  2005-06-17       Impact factor: 3.657

Review 2.  Purinergic signaling in the inner ear.

Authors:  Jun Ho Lee; Daniel C Marcus
Journal:  Hear Res       Date:  2007-09-29       Impact factor: 3.208

Review 3.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

4.  K+ secretion activated by luminal P2Y2 and P2Y4 receptors in mouse colon.

Authors:  J E Matos; B Robaye; J M Boeynaems; R Beauwens; J Leipziger
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

5.  P2X2 receptor mediates stimulation of parasensory cation absorption by cochlear outer sulcus cells and vestibular transitional cells.

Authors:  J H Lee; T Chiba; D C Marcus
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

6.  Large-conductance Ca2+ -activated K+ channel activation by apical P2Y receptor agonists requires hydrocortisone in differentiated airway epithelium.

Authors:  Nathan A Zaidman; Angela Panoskaltsis-Mortari; Scott M O'Grady
Journal:  J Physiol       Date:  2017-06-11       Impact factor: 5.182

7.  Phosphatidylinositol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels.

Authors:  G Loussouarn; K-H Park; C Bellocq; I Baró; F Charpentier; D Escande
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

8.  Apical membrane P2Y4 purinergic receptor controls K+ secretion by strial marginal cell epithelium.

Authors:  Daniel C Marcus; Jianzhong Liu; Jun Ho Lee; Elias Q Scherer; Margaret A Scofield; Philine Wangemann
Journal:  Cell Commun Signal       Date:  2005-11-02       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.